Several studies examining the effects of PPARγ on NAFLD have demonstrated enhanced expression of lipogenic genes and increased expression of PPARγ in animal models of steatotic liver [26–28]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.